Indeed, through a direct interaction with Podocalyxin, a plasma membrane glycoprotein abnormally expressed in several cancers, DNM2 regulates the microtubule dynamics leading to reduction of focal adhesions promoting cell migration [62]. Here, DNM2 is linked to cancer.